<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2021000200155</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x2021000200008</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estudio de utilización de albúmina en pacientes no críticos en un hospital de tercer nivel]]></article-title>
<article-title xml:lang="en"><![CDATA[Study of clinical use of albumin in non-critical patients in a third-level hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Guío]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perelló-Camacho]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Campillo-López]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zayas-Soriano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aznar-Saliente]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camacho-Romera]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario San Juan de Alicante Servicio de Farmacia ]]></institution>
<addr-line><![CDATA[San Juan de Alicante ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario San Juan de Alicante Sección de Endocrinología y Nutrición ]]></institution>
<addr-line><![CDATA[San Juan de Alicante ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>31</volume>
<numero>2</numero>
<fpage>155</fpage>
<lpage>159</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2021000200155&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2021000200155&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2021000200155&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El uso de albúmina vía intravenosa está extendido y respaldado por la evidencia científica en determinadas situaciones. Sin embargo, resulta común su uso para corregir un deficiente estado nutricional o un hallazgo analítico de hipoalbuminemia, a pesar de la falta de evidencia, el elevado coste y el riesgo de efectos adversos. El objetivo del trabajo es analizar y evaluar el uso de albúmina en un hospital de tercer nivel, tras la suspensión de su consideración como medicamento restringido y la implantación de la prescripción electrónica y, por tanto, la ausencia de necesidad de informar de la indicación y parámetros clínicos en la prescripción. Se realizó un estudio observacional prospectivo de cuatro semanas en el que se revisaron las prescripciones de albúmina. El tratamiento de datos se realizó mediante el paquete estadístico Stata. Se confirmó el excesivo e incorrecto uso de albúmina, ya que la mayor parte (54,5%) de las prescripciones no se ajustaban a las indicaciones de ficha técnica o a las principales recomendaciones, la única justificación fue corregir la hipoalbuminemia. Los parámetros analíticos nutricionales estaban en rango de desnutrición y ningún paciente tenía registro de peso corporal. Se detectaron tratamientos de larga duración, que en muchos casos se prolongaron hasta el alta hospitalaria. La mayor parte del coste total fue en prescripciones no indicadas. Los tres servicios hospitalarios con más consumo de albúmina fueron Medicina Interna, Oncología y Medicina Digestiva. Se considera necesario retomar la monitorización intensiva realizada hace años en el hospital por motivos clínicos, económicos y sostenibles.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY The use of intravenous albumin is widespread and supported by scientific evidence in certain situations. However, its use is common to improve a poor nutritional status or an analytical finding of hypoalbuminemia, despite the lack of evidence, the high cost and the risk of adverse effects. The objective of this study is to analyze and evaluate the use of albumin in a third-level hospital, after the suspension of its consideration as a restricted drug and the electronic prescription implementation, and therefore, the absence of the need to report the indication and clinical parameters in the prescription. A four-week prospective observational study was conducted where albumin prescriptions were reviewed. The data were processed using the Stata statistical software package. The excessive and wrong use of albumin is confirmed, since most of the prescriptions (54,5%) did not conform to the therapeutic indications of the data sheet or the main recommendations, the only justification was the correction of hypoalbuminemia. The blood test values showed malnutrition and no patient had a body weight record. Long-term treatments were detected and in many cases they were maintained until hospital discharge. Most of the total cost was in non-indicated prescriptions. The three hospital departments with the highest albumin consumption were Internal Medicine, Oncology and Gastroenterology. It is considered necessary to reintroduce the intensive monitoring performed years ago in the hospital for clinical, economic and sustainable reasons.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Albúmina]]></kwd>
<kwd lng="es"><![CDATA[desnutrición]]></kwd>
<kwd lng="es"><![CDATA[hipoalbuminemia]]></kwd>
<kwd lng="es"><![CDATA[agente biológico]]></kwd>
<kwd lng="en"><![CDATA[Albumin]]></kwd>
<kwd lng="en"><![CDATA[malnutrition]]></kwd>
<kwd lng="en"><![CDATA[hypoalbuminemia]]></kwd>
<kwd lng="en"><![CDATA[biological agents]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<collab>Sociedad Española de Nutrición Parenteral y Enteral</collab>
<source><![CDATA[Consenso multidisciplinar de la desnutrición hospitalaria en España]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Glosa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D'Erasmo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pisani]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ragno]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Romagnoli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Spagna]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Acca]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum albumin level at admission: mortality and clinical outcome in geriatric patients]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1997</year>
<volume>314</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Covinsky]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Covinsky]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Sehgal]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum Albumin Concentration and Clinical Assessments of Nutritional Status in Hospitalized Older People: Different Sides of Different Coins?]]></article-title>
<source><![CDATA[J Am Geriatr Soc]]></source>
<year>2002</year>
<volume>50</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>631-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caraceni]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Domenicali]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tovoli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Napoli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ricci]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Tufoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical indications for the albumin use: Still a controversial issue]]></article-title>
<source><![CDATA[Eur J Intern Med]]></source>
<year>2013</year>
<volume>24</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>721-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Flores]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez Tostado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Larios Deltoro]]></surname>
<given-names><![CDATA[YE]]></given-names>
</name>
<name>
<surname><![CDATA[Gardía Rentería]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rendón Félix]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar Parra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>2016</year>
<volume>33</volume>
<numero>4^sNutr. Hosp.</numero>
<issue>4^sNutr. Hosp.</issue>
<supplement>Nutr. Hosp.</supplement>
<page-range>872-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García de Lorenzo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Celaya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[García Cofrades]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García Luna]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[García Peris]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La Sociedad Española de Nutrición Parenteral y Enteral (SENPE) ante las administraciones públicas]]></article-title>
<source><![CDATA[Nutr Hosp]]></source>
<year>2011</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>251-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>Agencia española del medicamento</collab>
<source><![CDATA[Ficha técnica Albunorm 20%, 200 g/l solución para perfusión. 70739]]></source>
<year>31/0</year>
<month>3/</month>
<day>20</day>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lobo Támer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Desnutrición en pacientes hospitalizados: incidencias, factores de riesgo y costes]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Granada ]]></publisher-loc>
<publisher-name><![CDATA[Editorial de la Universidad de Granada]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<collab>Asociación española de farmacia hospitalaria</collab>
<article-title xml:lang=""><![CDATA[Formación continuada 2º curso]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutrición parenteral: Prescripción y seguimiento clínico]]></source>
<year>2003</year>
<page-range>1-22</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Hospital de la Santa Creu i Sant Pau]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendez]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[McClain]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Marsano]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Albumin Therapy in Clinical Practice]]></article-title>
<source><![CDATA[Nutr Clin Pract]]></source>
<year>2005</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>314-20</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
